Soluble ST2 fails to reflect persistent endothelial dysfunction or symptoms in post-acute sequelae of COVID-19
Annales Pharmaceutiques Françaises · 2026
DOI: 10.1016/j.pharma.2026.02.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annales Pharmaceutiques Françaises, 2026. Verfasst von David M Smadja und 6 weiteren Autor:innen. Beteiligte Einrichtung: PARCC, Inserm, Université Paris-Cité, 75015 Paris, France; Service d'Hématologie Biologique, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, F…. Hauptthemen laut MEDLINE: Interleukin-1 Receptor-Like 1 Protein, COVID-19, Endothelium, Vascular. Die Arbeit nennt 29 Literaturangaben. Gefördert von: AP-HP, Fondation de France, ANR.
Abstract (Originalsprache)
BACKGROUND: Soluble ST2 (sST2), the circulating decoy receptor of interleukin-33 (IL-33), has been validated as a prognostic biomarker of disease severity and vascular injury during acute COVID-19. However, its relevance in the context of post-acute sequelae of SARS-CoV-2 infection (PASC or long COVID) remains unclear. METHODS: We analyzed the association between plasma sST2 concentrations and clinical or vascular features in a prospective cohort of 137 long COVID patients (median age: 55 years; 49.6% male), encompassing 194 follow-up visits conducted 3 to 24 months after infection. Fatigue and dyspnea were systematically assessed, alongside full pulmonary function testing (PFTs), including diffusing capacity of the lung for carbon monoxide (DLCO). Plasma concentrations of sST2, VEGF-A, von Willebrand factor antigen (VWF: Ag) and circulating endothelial cells (CECs) were measured. RESULTS: sST2 concentrations were significantly elevated in hospitalized patients during the acute phase of COVID-19 compared to healthy controls (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PARCC, Inserm, Université Paris-Cité, 75015 Paris, France; Service d'Hématologie Biologique, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, France. Electronic address: david.smadja@aphp.fr.
- PARCC, Inserm, Université Paris-Cité, 75015 Paris, France; Service de Physiologie Respiratoire, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, France.
- PARCC, Inserm, Université Paris-Cité, 75015 Paris, France; Service d'Hématologie Biologique, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, France.
- PARCC, Inserm, Université Paris-Cité, 75015 Paris, France; Service d'Hématologie Biologique, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, France; Division of Plastic and Reconstructive Surgery, Cedars Sinai Ho…
- Service de Physiologie Respiratoire, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, France.
- PARCC, Inserm, Université Paris-Cité, 75015 Paris, France; Service de Réanimation Médicale, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, France.
Förderung
- AP-HP
- Fondation de France
- ANR
Zitieren
APA
Smadja, D. M., Günther, S., Rancic, J., Lellouch, A. G., Renaud, B., Diehl, J. L., & Philippe, A. (2026). Soluble ST2 fails to reflect persistent endothelial dysfunction or symptoms in post-acute sequelae of COVID-19. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2026.02.008
Vancouver
Smadja DM, Günther S, Rancic J, Lellouch AG, Renaud B, Diehl JL, et al. Soluble ST2 fails to reflect persistent endothelial dysfunction or symptoms in post-acute sequelae of COVID-19. Annales Pharmaceutiques Françaises. 2026. doi:10.1016/j.pharma.2026.02.008
BibTeX
@article{Smadja2026,
author = {Smadja, David M and Günther, Sven and Rancic, Jeanne and Lellouch, Alexandre G and Renaud, Bertrand and Diehl, Jean-Luc and Philippe, Aurélien},
title = {Soluble ST2 fails to reflect persistent endothelial dysfunction or symptoms in post-acute sequelae of COVID-19},
journal = {Annales Pharmaceutiques Françaises},
year = {2026},
doi = {10.1016/j.pharma.2026.02.008}
}
EUVIMED